Anxiety and Depression in Patients with Hormone-Dependent Breast Cancer during Neoadjuvant Endocrinotherapy

The problem of the quality of life of cancer patients, the study of the influence of premorbid psychological states on the course of tumor diseases and the role of cancer in changes in the psychology of patients, the staff of the Department of Oncology, Dnepropetrovsk Medical Academy has been dealing with for almost thirty years [1-3]. The authors showed that most patients, regardless of the location of the tumor, have impaired social adaptation, and almost half of them (48%) have an intra-psychic orientation of maladaptation, more than a third (37.5%) are extra-psychic, and only 14.2% do not pronounced social maladaptation. In the structure of maladaptation, anxiety and depression should play a leading role [4]. Despite the passage of time, the difference in healthcare systems, the achievements of medicine and its modern capabilities, psychological problems remain relevant today [5-7]. Anxiety and depression are perhaps not the most important factors that lead to a deterioration in the quality of life of patients, especially those with breast cancer [8, 9]. Both anxiety and depression have multifactorial causes, but the treatment that the patient receives has a significant effect on their severity [10-12].